Cresset Asset Management »

Silverback Therapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $303k 30k 10.05
2025-06-30 $526k 30k 17.45
2025-03-31 $355k 28k 12.58
2024-12-31 $293k 28k 10.55
2024-09-30 $355k 25k 14.50
2024-06-30 $208k 25k 8.51

More positions owned by Cresset Asset Management

Arista Networks Com Shs (ANET)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Erie Indty Cl A (ERIE)
Ishares Tr Core S&p500 Etf (IVV)
Reddit Cl A Put Option (RDDT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core Msci Eafe (IEFA)
Palantir Technologies Cl A Put Option (PLTR)
Ishares Tr Core S&p Scp Etf Put Option (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Put Option (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)

View all positions for Cresset Asset Management

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Vanguard Group
Standard Life Aberdeen
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics